Join
Vaxxinity Inc. logo

VAXX

NASDAQ

Vaxxinity Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2021
$0.11-0.02 (-16.47%)
News25/Ratings5

Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as dementia with Lewy Body and multiple system atrophy; and an anti-tau product candidate for various neurodegenerative conditions, including AD It is also developing UB-313 that targets Calcitonin Gene-Related Peptide to fight migraines; and Anti-PCSK9 that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events, as well as UB-612/UB-612A for Covid-19 prevention. The company has a collaboration with United Biomedical, Inc. for the development of UB-612 in Taiwan. Vaxxinity, Inc. was founded in 2014 and is based in Dallas, Texas.

Latest news

25 items

VAXX FAQ

7 questions
  • What does Vaxxinity Inc. do?
    Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as dementia with Lewy Body and multiple system atrophy; and an anti-tau product candidate for various neurodegenerative conditions, including AD It is also developing...
  • Where does VAXX stock trade?
    Vaxxinity Inc. (VAXX) is listed on NASDAQ.
  • What sector and industry is VAXX in?
    Vaxxinity Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • When did Vaxxinity Inc. go public?
    Vaxxinity Inc. (VAXX) completed its IPO in 2021.
  • What are analysts saying about VAXX?
    Vaxxinity Inc. has had 5 recent analyst actions on file. The most recent action was from Robert W. Baird: Outperform with a $700.00 price target on 2023-09-08. Recent price targets range from $700.00 to $2100.00.
  • What companies are similar to VAXX?
    Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare VAXX side-by-side with any of them on Quantisnow.
  • How can I track VAXX on Quantisnow?
    Quantisnow aggregates Vaxxinity Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow VAXX to receive live email and push alerts on every new disclosure.